We are live on ! Find out more
VIM

Veritas Investment Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 25.54%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+25.54%
3 Year Est. Return
+69.01%
5 Year Est. Return
+144.34%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$93.6M
Cap. Flow
+$33M
Cap. Flow %
2.96%
Top 10 Hldgs %
79.86%
Holding
61
New
1
Increased
16
Reduced
11
Closed
3

Top Buys

Rank Stock Value
1
HAS icon
Hasbro
HAS
+$42.2M
2
UNH icon
UnitedHealth
UNH
+$7.66M
3
LH icon
Labcorp
LH
+$4.87M
4
AVY icon
Avery Dennison
AVY
+$3.63M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.47M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$44M
2
V icon
Visa
V
+$531K
3
ORCL icon
Oracle
ORCL
+$360K
4
AMZN icon
Amazon
AMZN
+$289K
5
AAPL icon
Apple
AAPL
+$152K

Sector Composition

Rank Sector Weight
1 Healthcare 27.71%
2 Technology 26.9%
3 Financials 16.86%
4 Consumer Discretionary 9.1%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$125M 11.19%
932,556
+11,783
+1% +$1.5M
TMO icon
2
Thermo Fisher Scientific
TMO
$214B
$114M 10.24%
389,345
+4,305
+1% +$1.19M
UNH icon
3
UnitedHealth
UNH
$383B
$106M 9.53%
436,151
+31,828
+8% +$7.66M
MA icon
4
Mastercard
MA
$510B
$102M 9.11%
384,608
+8,625
+2% +$2.16M
LH icon
5
Labcorp
LH
$25.9B
$85.5M 7.66%
575,763
+34,891
+6% +$4.87M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$82.7M 7.41%
389,219
+16,749
+4% +$3.47M
CERN
7
DELISTED
Cerner Corp
CERN
$80.9M 7.24%
1,104,280
+15,810
+1% +$1.07M
FISV
8
Fiserv Inc
FISV
$28.8B
$70.5M 6.32%
773,495
+27,850
+4% +$2.44M
XYL icon
9
Xylem
XYL
$27.3B
$63.1M 5.66%
755,125
+26,085
+4% +$2.08M
CTSH icon
10
Cognizant
CTSH
$24.3B
$61.4M 5.5%
968,207
+36,445
+4% +$2.39M
AVY icon
11
Avery Dennison
AVY
$13.4B
$55.8M 5%
482,963
+33,135
+7% +$3.63M
HAS icon
12
Hasbro
HAS
$13.4B
$45.2M 4.05%
+427,815
New +$42.2M
APH icon
13
Amphenol
APH
$197B
$41.1M 3.68%
1,712,340
+67,960
+4% +$1.64M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.08T
$36.9M 3.3%
681,960
+18,720
+3% +$1.08M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.08T
$31.2M 2.79%
576,440
+27,780
+5% +$1.61M
ALGN icon
16
Align Technology
ALGN
$12.4B
$1.39M 0.12%
5,065
NTRS icon
17
Northern Trust
NTRS
$22.4B
$1.26M 0.11%
14,000
-1,300
-8% -$120K
AAPL icon
18
Apple
AAPL
$4.9T
$1.03M 0.09%
20,864
-3,120
-13% -$152K
PAYX icon
19
Paychex
PAYX
$41.4B
$780K 0.07%
9,476
ECL icon
20
Ecolab
ECL
$78.6B
$649K 0.06%
3,298
+915
+38% +$170K
UNP icon
21
Union Pacific
UNP
$172B
$634K 0.06%
3,750
-300
-7% -$51.4K
INTU icon
22
Intuit
INTU
$86.3B
$622K 0.06%
2,379
BNY
23
Bank of New York Mellon
BNY
$106B
$547K 0.05%
12,387
-2,000
-14% -$94K
DG icon
24
Dollar General
DG
$28.1B
$507K 0.05%
3,750
WEC icon
25
WEC Energy
WEC
$35.8B
$484K 0.04%
5,810

Similar funds

Veritas Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Veritas Investment Management held 61 positions worth $1.12B, up 9.2% from $1.02B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Veritas Investment Management's Q2 2019 filing shows 1 new, 16 increased, 11 reduced and 3 closed positions. Its largest new stake was Hasbro: 427,815 shares worth $45.2M. The largest sale was CVS Health, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Veritas Investment Management's largest Q2 2019 buy was Hasbro: 427,815 shares worth $45.2M.
  • Veritas Investment Management added most to UnitedHealth in Q2 2019, an estimated $7.66M increase.
  • Veritas Investment Management's biggest Q2 2019 reduction was CVS Health, cutting an estimated $44M.
  • Veritas Investment Management fully exited Oracle in Q2 2019, selling an estimated $360K.
  • Veritas Investment Management's ten largest holdings make up 80% of its $1.12B portfolio in Q2 2019.
  • Veritas Investment Management opened 1 new position and closed 3 in Q2 2019.
  • Veritas Investment Management's portfolio value rose 9.2% quarter-over-quarter to $1.12B.

Based on Veritas Investment Management's 13F filing for Q2 2019, filed 5 Aug 2019.